#hvhebron
First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study www.frontiersin.org/journals/onc... #hvhebron #onco [Text complet]
Frontiers | First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study
www.frontiersin.org
January 8, 2025 at 1:26 PM Everybody can reply
Successful Ex Situ Reduction During Hypothermic Oxygenated Machine Perfusion in a Severely Steatotic Graft From a Donor After Brain Death: An Anecdote? www.ectrx.org/detail/archi... #hvhebron #chbpt
EXPERIMENTAL AND CLINICAL TRANSPLANTATION
Key words : Cold ischemia time, Ischemia-reperfusion injury, Marginal liver graft, Reduction liver transplantation
www.ectrx.org
January 16, 2025 at 2:41 PM Everybody can reply
Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer www.frontiersin.org/journals/onc... #hvhebron #onco [Text complet]
Frontiers | Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer
www.frontiersin.org
February 4, 2025 at 11:40 AM Everybody can reply
Correction: Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey link.springer.com/article/10.1... #hvhebron #ccol
June 12, 2025 at 10:58 AM Everybody can reply